These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 17678967)

  • 21. Mechanisms of cell signaling and inflammation in Alzheimer's disease.
    Ho GJ; Drego R; Hakimian E; Masliah E
    Curr Drug Targets Inflamm Allergy; 2005 Apr; 4(2):247-56. PubMed ID: 15853747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroscience. The dark side of glia.
    Miller G
    Science; 2005 May; 308(5723):778-81. PubMed ID: 15879185
    [No Abstract]   [Full Text] [Related]  

  • 23. Targeting toll-like receptor 4 to modulate neuroinflammation in central nervous system disorders.
    Leitner GR; Wenzel TJ; Marshall N; Gates EJ; Klegeris A
    Expert Opin Ther Targets; 2019 Oct; 23(10):865-882. PubMed ID: 31580163
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of inflammation in neurodegenerative diseases.
    Minghetti L
    Curr Opin Neurol; 2005 Jun; 18(3):315-21. PubMed ID: 15891419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of interleukin-1beta by interleukin-4 in lipopolysaccharide-treated mixed glial cultures: microglial-dependent effects.
    Cao L; Fei L; Chang TT; DeLeo JA
    J Neurochem; 2007 Jul; 102(2):408-19. PubMed ID: 17442043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroglia in neurodegeneration.
    Heneka MT; Rodríguez JJ; Verkhratsky A
    Brain Res Rev; 2010 May; 63(1-2):189-211. PubMed ID: 19944719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic Role and Drug Delivery Potential of Neuroinflammation as a Target in Neurodegenerative Disorders.
    Singh A; Chokriwal A; Sharma MM; Jain D; Saxena J; Stephen BJ
    ACS Chem Neurosci; 2017 Aug; 8(8):1645-1655. PubMed ID: 28719178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroprotection from complement-mediated inflammatory damage.
    Kulkarni AP; Kellaway LA; Lahiri DK; Kotwal GJ
    Ann N Y Acad Sci; 2004 Dec; 1035():147-64. PubMed ID: 15681806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitogen-activated protein kinase-activated protein kinase 2 in neuroinflammation, heat shock protein 27 phosphorylation, and cell cycle: role and targeting.
    Gurgis FM; Ziaziaris W; Munoz L
    Mol Pharmacol; 2014 Feb; 85(2):345-56. PubMed ID: 24296859
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases.
    Takenouchi T; Sekiyama K; Sekigawa A; Fujita M; Waragai M; Sugama S; Iwamaru Y; Kitani H; Hashimoto M
    Arch Immunol Ther Exp (Warsz); 2010 Apr; 58(2):91-6. PubMed ID: 20143170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-inflammatory effects of aromatic-turmerone through blocking of NF-κB, JNK, and p38 MAPK signaling pathways in amyloid β-stimulated microglia.
    Park SY; Jin ML; Kim YH; Kim Y; Lee SJ
    Int Immunopharmacol; 2012 Sep; 14(1):13-20. PubMed ID: 22728094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroinflamm-aging and neurodegenerative diseases: an overview.
    Pizza V; Agresta A; D'Acunto CW; Festa M; Capasso A
    CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):621-34. PubMed ID: 21631404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of glia phenotype modulators based on select glial function regulatory signaling pathways.
    Lee SH; Suk K
    Expert Opin Drug Discov; 2018 Jul; 13(7):627-641. PubMed ID: 29676181
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Microglia Mediated Neuroinflammation: Focus on PI3K Modulation.
    Cianciulli A; Porro C; Calvello R; Trotta T; Lofrumento DD; Panaro MA
    Biomolecules; 2020 Jan; 10(1):. PubMed ID: 31947676
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Toll-like receptors in neurodegeneration.
    Okun E; Griffioen KJ; Lathia JD; Tang SC; Mattson MP; Arumugam TV
    Brain Res Rev; 2009 Mar; 59(2):278-92. PubMed ID: 18822314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mast cells, glia and neuroinflammation: partners in crime?
    Skaper SD; Facci L; Giusti P
    Immunology; 2014 Mar; 141(3):314-27. PubMed ID: 24032675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Microglial signalling cascades in neurodegenerative disease.
    Pocock JM; Liddle AC
    Prog Brain Res; 2001; 132():555-65. PubMed ID: 11545020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamate release from astrocytes in physiological conditions and in neurodegenerative disorders characterized by neuroinflammation.
    Vesce S; Rossi D; Brambilla L; Volterra A
    Int Rev Neurobiol; 2007; 82():57-71. PubMed ID: 17678955
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomaterials and glia: Progress on designs to modulate neuroinflammation.
    Tsui C; Koss K; Churchward MA; Todd KG
    Acta Biomater; 2019 Jan; 83():13-28. PubMed ID: 30414483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease.
    Dickson DW; Lee SC; Mattiace LA; Yen SH; Brosnan C
    Glia; 1993 Jan; 7(1):75-83. PubMed ID: 8423065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.